Life Molecular Imaging (LMI) was founded in 2012 with the acquisition of the molecular imaging research and development portfolio of Bayer Pharma AG by Piramal and is now part of Life Healthcare’s Alliance Medical. Life Molecular Imaging is developing a product portfolio of innovative molecular imaging tracers that address major clinical needs in neurology and cardiology. Its research and development portfolio focuses on neu...
Life Molecular Imaging (LMI) was founded in 2012 with the acquisition of the molecular imaging research and development portfolio of Bayer Pharma AG by Piramal and is now part of Life Healthcare’s Alliance Medical. Life Molecular Imaging is developing a product portfolio of innovative molecular imaging tracers that address major clinical needs in neurology and cardiology. Its research and development portfolio focuses on neurodegenerative and cardiovascular diagnostics, including a next-generation Tau tracer for Alzheimer’s disease and progressive supranuclear palsy.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.